Loading...

Becton, Dickinson and Company

BDXANYSE
Healthcare
Medical - Instruments & Supplies
$59.24
$-1.36(-2.24%)

Becton, Dickinson and Company (BDXA) Stock Overview

Explore Becton, Dickinson and Company’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 66.3/100

Key Financials

Market Cap48.7B
P/E Ratio32.82
EPS (TTM)$2.76
ROE0.06%

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

BDXA Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Becton, Dickinson and Company (BDXA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 32.82 and a market capitalization of 48.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Revenue Growth
4.16%
4.16%
Profit Growth
$5.19
14.89%
EPS Growth
$5.19
18.31%
Operating Margin
11.33%
13.55%
ROE
5.86%
14.89%
Dividend Yield
0.00%
2.44%
Analyst Recommendations data is not available for BDXAAnalyst Recommendations details for BDXA are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Founded

2017

Frequently Asked Questions

;